Acquisition leverage Since CooperSurgical acquired Incisive Surgical, INSORB sits within a larger distribution and product portfolio, providing a clear path to rapid scale through existing channels and loyalty among healthcare buyers.

Cosmetic closure advantage The INSORB staple combines absorbable material with rapid closure and avoids metal removal, addressing surgeon demand for cosmetic outcomes and workflow efficiency.

Portfolio synergies Opportunities exist to cross-sell INSORB with CooperSurgical's wound care, closure devices, and surgical kits, expanding usage in hospitals and ambulatory settings.

Target customer segments Primary targets include high-volume hospitals and ambulatory surgery centers that value efficient closures and cosmetic results, enabling scalable adoption across clinics.

Competitive differentiation Positioned as a niche absorbable closure option, INSORB differentiates from traditional sutures and metal staples, offering reduced post-op follow-up and potential cost savings for surgeons and facilities.